Skip to main content
padlock icon - secure page this page is secure

Correction of factor XI deficiency by liver transplantation

Buy Article:

$52.00 + tax (Refund Policy)

Orthotopic liver transplantation for other diseases typically results in a coincidental cure for hemophilia A and B; however, long-term outcomes of liver transplant in hemophilia C are not very well described. Herein, the authors report a patient of severe congenital factor XI (FXI) deficiency who received an orthotopic liver transplant. The authors discuss the perioperative management and long-term outcomes. The normalization of his FXI levels confirms that the liver is the most clinically relevant site of synthesis of FXI.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: bleeding; clotting factors; factor XI deficiency; hemophilia; liver transplant

Document Type: Research Article

Affiliations: 1: Division of Hematology and Oncology 2: Division of Laboratory Medicine and Pathology, –Jacksonville, Florida 3: Division of Hematology and Oncology, Mayo Clinic, Rochester, Minnesota, USA

Publication date: December 1, 2015

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more